Scholarlink

Purpose of Review <p>To summarize up to date literature comparing percutaneous nerve evaluation (PNE) to the Staged lead approach in identifying optimal candidates for sacral neuromodulation (SNM) in the management of overactive bladder (OAB) or neurogenic bladder (NGB). Additionally, to understand pros and cons of each procedure including patient specific factors, patient experience, and cost to the healthcare system.</p> Recent Findings <p>In general, a staged approach has better predictability for those who may benefit from SNM for urinary symptoms. However, the reliability of PNE has increased with advancements to the monopolar lead.</p> Summary <p>Stage 1 tined lead test is superior at predicting patients who may benefit from SNM, but PNE has undergone recent advancements improving its efficacy and should be considered a viable option for testing in select patients. Head to head studies are necessary to compare symptom outcomes, patient experience and cost effectiveness of each approach.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sacral Neuromodulation (SNM): Can Percutaneous Nerve Evaluation (PNE) Really Compete with Stage 1 to Predict Outcomes?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • Hannah Glick,
  • Rachna Sridhar,
  • Priyanka Gupta

摘要

Purpose of Review

To summarize up to date literature comparing percutaneous nerve evaluation (PNE) to the Staged lead approach in identifying optimal candidates for sacral neuromodulation (SNM) in the management of overactive bladder (OAB) or neurogenic bladder (NGB). Additionally, to understand pros and cons of each procedure including patient specific factors, patient experience, and cost to the healthcare system.

Recent Findings

In general, a staged approach has better predictability for those who may benefit from SNM for urinary symptoms. However, the reliability of PNE has increased with advancements to the monopolar lead.

Summary

Stage 1 tined lead test is superior at predicting patients who may benefit from SNM, but PNE has undergone recent advancements improving its efficacy and should be considered a viable option for testing in select patients. Head to head studies are necessary to compare symptom outcomes, patient experience and cost effectiveness of each approach.